References
Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localized disease. Eur Urol 2011; 59(1): 61–71
Sadovsky R, Basson R, Krychman M, et al. Cancer and sexual problems. J Sex Med 2010; 7 (1 Pt 2): 349–73
Glina S. Erectile dysfunction after radical prostatectomy: treatment options. Drugs Aging 2011; 28(4): 257–66
Mulhall JP, Bella AJ, Briganti A, et al. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med 2010; 7 (4 Pt 2): 1687–98
Burnett AL. Erectile dysfunction following radical prostatectomy. JAMA 2005; 293(21): 2648–53
Hatzimouratidis K, Amar E, Eardley E, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010; 57(8): 804–14
Mulhall JP, Parker M, Waters BW, et al. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int 2010; 105(1): 37–41
British Medical Association and the Royal Pharmaceutical Society of Great Britain. British national formulary. No. 62. London: BMJ Publishing Group Ltd and RPS Publishing, 2011 Sep
Zippe CD, Jhaveri FM, Klein EA, et al. Role of Viagra after radical prostatectomy. Urology 2000; 55(2): 241–5
Hatzimouratidis K, Burnett AL, Hatzichristou D, et al. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur Urol 2009; 55(2): 334–47
Montorsi F, Nathan HP, McCullough A, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo-controlled trial. J Urol 2004; 172(3): 1036–41
Brock G, Nehra A, Lipshultz LI, et al. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 2003; 170 (4 Pt 1): 1278–83
Padma-Nathan H, McCullough AR, Levine LA, et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008; 20(5): 479–86
Bannowsky A, Schulze H, van der Horst C, et al. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int 2008; 101(10): 1279–83
Montorsi F, Brock G, Lee J, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 54(4): 924–31
Garcia FJ, Brock G. Current state of penile rehabilitation after radical prostatectomy. Curr Opin Urol 2010; 20(3): 234–40
Mulhall JP. Does on-demand vardenafil improve erectile function recovery after radical prostatectomy? Nat Clin Pract Urol 2009; 6(1): 14–5
Alexandre B, Lemaire A, Desvaux P, et al. Intracavernous injections of prostaglandin E1 for erectile dysfunction: patient satisfaction and quality of sex life on long-term treatment. J Sex Med 2007; 4(2): 426–31
Albaugh J, Ferrans CE. Patient-reported pain with initial intracavernosal injection. J Sex Med 2009; 6(2): 513–9
Costabile RA, Spevak M, Fishman IJ, et al. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol 1998; 160(4): 1325–8
McCullough AR, Hellstrom WG, Wang R, et al. Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol 2010; 183(6): 2451–6
Baniel J, Israilov S, Segenreich E, et al. Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy. BJU Int 2001; 88(1): 58–62
Montague DK, Angermeier KW. Penile prosthesis implantation. Urol Clin North Am 2001; 28(2): 355–61
Rights and permissions
About this article
Cite this article
Early intervention is important when treating erectile dysfunction associated with radical prostatectomy. Drugs Ther. Perspect 27, 13–17 (2011). https://doi.org/10.2165/11606280-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11606280-000000000-00000